Influence of polypropylene mesh degradation on tissue inflammatory reaction
Journal of Biomedical Materials Research Part A · 2023-08 · 111 (8) · 1110-1119
DOI: 10.1002/jbm.a.37494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 30.12.2022. Verfasst von Hongshi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biohybrid & Medical Textiles (BioTex), Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany. Hauptthemen laut MEDLINE: Polypropylenes, Surgical Mesh. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polypropylene degradation in vivo appears as mesh surface cracking and peeling. This aging process of the mesh, resulting in the lack of bio‐stability, contradicts the requirement of biocompatibility. However, to date, it is still not clearly established how much this mesh degradation influences the local tissue response with subsequent clinical consequences. This study aims to find out whether mesh degradation is correlated with elevated inflammatory tissue reaction through analyzing 100 human PP meshes explanted from the pelvic floor. A degradation classification method, based on standard pathological H&E stained slides of the explanted mesh via light microscope, was developed to classify the mesh degradation into four classes (no, mild, moderate and severe degradation). The peri‐filamentary tissue inflammatory reaction was analyzed by scoring the expression of the most common cell markers for the innate immune reaction: CD68 as marker for macrophage, CD86 for M1 subtype, CD163 for M2 subtype, CD3 for T‐lymphocyte and CD15 for neutrophil granulocytes. The correlation between immune cell expression, degradation classification and time of implantation of the meshes are evaluated with Spearman‐Rho‐Test. Mesh degradation worsens significantly ( p < .001) with longer time of implantation. The increasing tendency of CD68 expression by mesh with higher degradation class indicates that the number of macrophages increases with worsening mesh degradation. The significantly increased expression of CD163 and CD3 cell by severely degraded mesh demonstrate the increased number of M2 and T‐Lymphocyte when mesh degradation becomes severe. None of the inflammatory cells show the usual declining expression with longer time of implantation. The result of this study suggests that the degradation of PP mesh results in an elevated local inflammatory reaction in female pelvic floor. A material with better bio‐stability for mesh implant in pelvic floor is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biohybrid & Medical Textiles (BioTex), Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, Germany.
- FEG Textiltechnik mbH, Aachen, Germany.
- Institute for Pathology at the Düren Hospital, Düren, Germany.
- Department of General, Visceral and Transplant Surgery at the University Hospital of the RWTH Aachen, Aachen, Germany.
ORCID-Profile: Hongshi Wang
Zitieren
APA
Wang, H., Klosterhalfen, B., Klinge, U., Müllen, A., & Jockenhoevel, S. (2023). Influence of polypropylene mesh degradation on tissue inflammatory reaction. Journal of Biomedical Materials Research Part A, 111(8), 1110-1119. https://doi.org/10.1002/jbm.a.37494
Vancouver
Wang H, Klosterhalfen B, Klinge U, Müllen A, Jockenhoevel S. Influence of polypropylene mesh degradation on tissue inflammatory reaction. Journal of Biomedical Materials Research Part A. 2023;111(8):1110-1119. doi:10.1002/jbm.a.37494
BibTeX
@article{Wang2023,
author = {Wang, Hongshi and Klosterhalfen, Bernd and Klinge, Uwe and Müllen, Andreas and Jockenhoevel, Stefan},
title = {Influence of polypropylene mesh degradation on tissue inflammatory reaction},
journal = {Journal of Biomedical Materials Research Part A},
year = {2023},
volume = {111},
number = {8},
pages = {1110--1119},
doi = {10.1002/jbm.a.37494}
}
EUVIMED